Karla Vega

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
INTRODUCTION Disruption of vulnerable atherosclerotic plaque is the precipitating factor that culminates in thrombosis and ischemia. Current technologies do not have sufficient power to identify subtle thrombogenic lesions (ie, ulcers) in the arterial endoluminal surfaces nor reliably predict markers for future symptomatology. We developed an ultra-thin(More)
  • 1